Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles.

The interaction of membrane-active amphiphiles with a series of MDR Chinese hamster ovary (CHO) cell lines was investigated. Cross-resistance to cationic amphiphiles was observed, which was effectively sensitised by verapamil. MDR cells showed collateral sensitivity to polyoxyethylene amphiphiles (Triton X-100/Nonidet P-40), which reached a maximum at 9-10 ethylene oxide units. Resistant lines were also highly collaterally sensitive (17-fold) to dibutylphthalate. mdrl transfectants showed cross-resistance to cationic amphiphiles, but no collateral sensitivity to nonionic species. Triton X-100/Nonidet P-40 inhibited 3H-azidopine photoaffinity labelling at low concentrations, perhaps reflecting a specific interaction with P-glycoprotein. Further investigation of the molecular basis of collateral sensitivity revealed that association of 3H-Triton X-100 with MDR cells reached steady state levels rapidly, and occurred by a non-mediated mechanism. The equilibrium level of X-100 uptake was inversely related to drug resistance. Collateral sensitivity is thus not a result of decreased Triton X-100 association with the cell. The fluorescent probe merocyanine 540 was used to examine the MDR plasma membrane microenvironment for physicochemical changes. Increasing levels of drug resistance correlated with a progressive shift in the mean cell fluorescence to lower levels, which suggests that the packing density in the outer leaflet of MDR cells is increased relative to that of the drug-sensitive parent.

[1]  S. Hui,et al.  Merocyanine 540 as a probe to monitor the molecular packing of phosphatidylcholine: a monolayer epifluorescence microscopy and spectroscopy study. , 1992, Biochimica et biophysica acta.

[2]  F. Sharom,et al.  ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.

[3]  A. Ramu,et al.  Reduced ouabain-sensitive potassium entry as a possible mechanism of multidrug-resistance in P388 cells. , 1991, Biochemical pharmacology.

[4]  M. Sehested,et al.  Relationship of VP-16 to the Classical Multidrug Resistance Phenotype1 , 2006 .

[5]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[6]  J. Jardillier,et al.  Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. , 1992, Cancer research.

[7]  P. Williamson,et al.  Merocyanine 540, a fluorescent probe sensitive to lipid packing. , 1983, Biochimica et biophysica acta.

[8]  V. Ling.  Drug resistance and membrane alteration in mutants of mammalian cells. , 1975, Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie.

[9]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[10]  J. Riordan,et al.  Multidrug-resistance phenotype in Chinese hamster ovary cells. , 1983, Cancer treatment reports.

[11]  A. Ramu,et al.  Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells. , 1983, Cancer research.

[12]  I. Pastan,et al.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  V. Ling,et al.  Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. , 1990, Advances in pharmacology.

[14]  L. Rosário,et al.  Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine. , 1991, Biochemical pharmacology.

[15]  P. Gros,et al.  A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Riordan,et al.  Genetic and biochemical characterization of multidrug resistance. , 1985, Pharmacology & therapeutics.

[17]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[18]  P. Gros,et al.  Lipophilic cations: a group of model substrates for the multidrug-resistance transporter. , 1992, Biochemistry.

[19]  D. Housman,et al.  Genetics of multidrug resistance: relationship of a cloned gene to the complete multidrug resistant phenotype. , 1987, Cancer research.

[20]  L. Greenberger,et al.  Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein. , 1990, The Journal of biological chemistry.

[21]  V. Ling,et al.  Membrane Mutants of Mammalian Cells in Culture , 1978 .

[22]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[23]  V. Ling,et al.  Co-amplification of double minute chromosomes, multiple drug resistance, and cell surface P-glycoprotein in DNA-mediated transformants of mouse cells , 1984, Molecular and cellular biology.

[24]  A. Sartorelli,et al.  The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. , 1983, The Journal of biological chemistry.

[25]  V. Ling,et al.  P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  J. Till,et al.  Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivity , 1976, Journal of cellular physiology.

[27]  M. Sheetz,et al.  Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[28]  I. Tamai,et al.  Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. , 1991, The Journal of biological chemistry.

[29]  D. Kessel,et al.  Membrane alterations associated with progressive adriamycin resistance. , 1982, Biochemical pharmacology.

[30]  A. Safa,et al.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. , 1987, The Journal of biological chemistry.

[31]  L. Greenberger,et al.  Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b. , 1991, The Journal of biological chemistry.

[32]  V. Ling,et al.  Altered plasma membrane ultrastructure in multidrug-resistant cells. , 1988, Biochimica et biophysica acta.

[33]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[34]  A. Helenius,et al.  Solubilization of membranes by detergents. , 1975, Biochimica et biophysica acta.

[35]  Alan S. Waggoner,et al.  Dye Probes of Cell, Organelle, and Vesicle Membrane Potentials , 1985 .

[36]  R. Jackson,et al.  Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. , 1986, Cancer research.

[37]  V. Ling,et al.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.

[38]  W. Mellado,et al.  Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins. , 1988, Biochemical pharmacology.

[39]  D. Kessel.  Probing membrane alterations associated with anthracycline resistance using fluorescent dyes. , 1988, Biochemical pharmacology.